The largest database of trusted experimental protocols

Sigmafast protease inhibitor

Manufactured by Merck Group
Sourced in United States

SigmaFast protease inhibitor is a laboratory product developed by Merck Group. It is designed to inhibit the activity of proteases, which are enzymes that break down proteins. The core function of SigmaFast protease inhibitor is to prevent protein degradation during sample preparation and analysis.

Automatically generated - may contain errors

39 protocols using sigmafast protease inhibitor

1

Immunoblotting for UBASH3A Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in RIPA buffer (Boston Bioproducts) supplemented with SigmaFast protease inhibitors (Sigma Aldrich). Protein samples (20 µg) were separated on 10% SDS–polyacrylamide gels and then transferred to a polyvinylidene difluoride membrane. Immunoblotting was performed using rabbit polyclonal antibodies directed against mouse UBASH3A at 4 ºC overnight, followed by goat anti-rabbit secondary antibody (Millipore, 12–348) at room temperature for 45 min. The rabbit anti-UBASH3A polyclonal antibody was produced by Thermo Scientific using the oligopeptide EKLQEFWRESRRQCAKNR (amino acid residues 86–103) as an antigen. Binding of the secondary antibody was detected by the Western bright ECL detection kit (Advansta Corporation). The membrane was then stripped with Restore plus Western Blot stripping buffer (Thermo Scientific) and re-probed with the rabbit anti-α tubulin polyclonal antibody (Abcam, ab4074).
+ Open protocol
+ Expand
2

Western Blot Analysis of M2 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell sediment was lysed in extraction buffer (1% Triton-X-100, 1mMEDTA, 20mMTris-HCl, pH 7.4) containing proteinase inhibitor Sigma Fast Protease Inhibitors (Sigma). After 10 min on ice, the lysates were clarified by microcentrifugation for 1 min, and the supernatants were analysed by electrophoresis on 12.5% polyacrylamide gels. Immunoblotting was done as described by Betakova et al. [29 (link)] using rabbit anti-M2, Protein A-horseradish peroxidase conjugate (BioRad) and 3,3′-Diaminobenzidine (DAB) Enhanced Liquid Substrate System tetrahydrochloride (Sigma).
+ Open protocol
+ Expand
3

Recombinant DNA and Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Restriction enzyme digests, DNA ligations, and other recombinant DNA procedures were performed using standard protocols. Mutagenesis was performed using the QuikChange site-directed mutagenesis method (Stratagene) with the KOD polymerase (Novagen). DNA constructs used for transfection were purified from E. coli DH5α using Qiagen Plasmid kits according to the manufacturer’s protocol. All DNA constructs were sequence verified. Lysis buffer used for purifying proteins from insect cells was composed of 50 mM Tris-HCl (pH 7.6), 300 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol, 0.075% (v/v) 2-mercaptoethanol, 1 mM benzamidine, 1 mM PMSF. Lysis buffer was supplemented with SigmaFast protease inhibitors (EDTA-free) at 1 tablet/100 ml (Sigma). Wash buffer A was the same as lysis buffer without PMSF and protease inhibitors. High salt wash buffer B was the same as buffer A with 500 mM NaCl. All protein concentrations were calculated using the Beer-Lambert law by measuring the absorbance at 280 nm. Theoretical extinction coefficients were calculated using the ProtParam tool at the ExPASy proteomics server (http://www.expasy.org).
See Supplementary Information for a detailed description of the methods and materials used in this study.
+ Open protocol
+ Expand
4

Immunoprecipitation of c10orf118 from Conditioned Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 70–80% confluence in a T-75 flask, the CM was harvested from all the cell lines and centrifuged at 14,000× g for 15 min at 4 °C, to remove insoluble debris. A 4-mL aliquot was concentrated to 1 mL volume into GyroVap and desalted using PD-10 Desalting Columns (GE Healthcare). The CM were poured into 15-mL tubes, frozen and lyophilized to dryness. The samples were resuspended with 50 µL of RIPA buffer containing 1× Sigma FAST Protease Inhibitors. Samples were pre-cleared with 50% G-Sepharose beads in RIPA buffer + protease inhibitors for 2 h at 4 °C on an orbital shaker. Beads were removed by centrifugation at 10,000 rpm for 1 min. The c10orf118 antibody (2.5 µg) was added to the sample and incubated at 4 °C overnight on an orbital shaker. To collect the immunocomplex, G-Sepharose beads were added to the sample and incubated at 4 °C overnight. All immunoprecipitates were washed five times with RIPA buffer. Beads were boiled in 3× sample buffer for 5 min at 95 °C and centrifuged. Eluates were analysed with SDS-PAGE and western blot.
+ Open protocol
+ Expand
5

Hamster Immunogenicity Study of CD0873 and CDTcdB-RBD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female Golden Syrian hamsters aged 12–16 weeks, weighing approximately 150 g were purchased from Janvier Labs and housed in IVCs. Hamsters were randomly divided into 4 groups: Experimental group given capsules containing recombinant CD0873 in excipient (n = 4), experimental group given capsules containing recombinant CDTcdB-RBD in excipient (n = 4), non-immunised i.e., naïve negative control group (n = 2) and a group given capsules containing excipient only (n = 2). The purpose of this latter group was to check if the capsule or excipient contributed towards any immunogenicity detected in experimental groups. Oral dosing with capsules was performed on days 1, 15 and 30. Hamsters were euthanised 14 days post final immunisation (2.16). Blood was collected by cardiac puncture, left to clot overnight at 4 °C and serum harvested after centrifugation. A section of the ileum was fixed in 10% (v/v) neutral buffered formalin (NBF) (Sigma) for histological analysis (2.15). The remainder of the small intestine was placed in 5 mL PBS containing SIGMAFAST™ protease inhibitors (Sigma ), flushed through twice with 1 mL of this suspension then the supernatant collected after centrifugation. Serum and intestinal fluid were filter-sterilised and stored at −80 °C.
+ Open protocol
+ Expand
6

Whole Cell Lysate Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell lysate was prepared using RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH8.0, SIGMAFAST™ Protease Inhibitors (Sigma-Aldrich, Cat# S8830-20TAB) and PhosSTOP EASYpack phosphatase inhibitor cocktail (Roche, Cat# 4906837001). Protein concentration was determined by Bradford assay (Bio-Rad, Cat# 5000006). 50–30 μg total proteins were separated by 7.5% or 10% tris–glycine polyacrylamide gel, with overnight incubation with primary antibodies (Table S1) and followed by a 1:10,000 dilution of horseradish peroxidase (HRP)-conjugated secondary antibodies. HRP signals were detected using Western Lightning® Ultra Chemiluminescence Substrate (PerkinElmer INC., Cat# NEL113001EA) and images captured by a UVP ChemStudio Plus BioImaging system. The densitometry of blot bands was quantified using Image Lab 6.0 software.
+ Open protocol
+ Expand
7

Purification of Recombinant cTXNPx from L. amazonensis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression plasmid pPOPINF containing ORF for cTXNPx from L. amazonensis (AY842247.1) tagged with N-terminal 6xHIS-tag was transformed into BL21 (DE3) competent cells (Agilent Technologies). One litre LB-ampicillin cultures were induced to express recombinant protein by addition of 1M isopropyl β-D-1-thiogalactopyranoside (IPTG). After 20 h of incubation at 30°C, cells were pelleted and resuspended in 50 mL of lysis buffer (20 mM Tris-HCI pH 7.5, 500 mM NaCI, 30 mM imidazole and 2 mM β-mercaptoethanol) with one tablet of Sigma-Fast protease inhibitors (Sigma-Aldrich). Cell pellets were further lysed by sonication and proteins were purified using His-tag affinity chromatography (HisTrap HP-1 mL column, GE healthcare). The cTXNPx peak fractions were pooled and concentrated to approximately 1 mg/mL as determined spectrophotometrically using a NanoDrop at 280 nm.
+ Open protocol
+ Expand
8

Recombinant DNA and Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Restriction enzyme digests, DNA ligations, and other recombinant DNA procedures were performed using standard protocols. Mutagenesis was performed using the QuikChange site-directed mutagenesis method (Stratagene) with the KOD polymerase (Novagen). DNA constructs used for transfection were purified from E. coli DH5α using Qiagen Plasmid kits according to the manufacturer’s protocol. All DNA constructs were sequence verified. Lysis buffer used for purifying proteins from insect cells was composed of 50 mM Tris-HCl (pH 7.6), 300 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol, 0.075% (v/v) 2-mercaptoethanol, 1 mM benzamidine, 1 mM PMSF. Lysis buffer was supplemented with SigmaFast protease inhibitors (EDTA-free) at 1 tablet/100 ml (Sigma). Wash buffer A was the same as lysis buffer without PMSF and protease inhibitors. High salt wash buffer B was the same as buffer A with 500 mM NaCl. All protein concentrations were calculated using the Beer-Lambert law by measuring the absorbance at 280 nm. Theoretical extinction coefficients were calculated using the ProtParam tool at the ExPASy proteomics server (http://www.expasy.org).
See Supplementary Information for a detailed description of the methods and materials used in this study.
+ Open protocol
+ Expand
9

Western Blot Analysis of Phospho-STAT3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were resuspended in ice-cold lysis buffer (50 mM Tris, 150 mM NaCl, 10% glycerol, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM NaF, 1.5 mM Na 3 VO 4 and 1 mM EDTA), supplemented with SIGMAFAST protease inhibitors (Sigma-Aldrich) and benzonase (Merck Millipore, Billerica, MA, USA, 25 U per cell pellet), and lysed for 30 min at 4 °C with rotation. Samples were then centrifuged at 17 000 g for 20 min at 4 °C. Supernatants were assayed for protein concentration using the Pierce 660 nm protein assay and diluted to the same protein concentration with lysis buffer. Aliquots corresponding to 10 μg of cell protein were diluted with 5 × SDS-PAGE sample buffer, heated to 95 °C for 10 min and centrifuged at 12 000 g for 5 min at room temperature. Samples were run on a 10% SDS-PAGE gel, transferred to polyvinylidene difluoride and analyzed by immunoblot using polyclonal rabbit antibody raised against mouse phospho-STAT3 (Cell Signaling, Danvers, MA, USA), mouse monoclonal antibody raised against beta actin (Abcam, Cambridge, MA, USA), anti-mouse IgG, HRP conjugate (Promega, Fitchburg, WI, USA) and anti-rabbit IgG, HRP conjugate (Dako, Carpinteria, CA, USA).
+ Open protocol
+ Expand
10

Hydroxylation Assay for HIF2α-CODD

Check if the same lab product or an alternative is used in the 5 most similar protocols
The indirect hydroxylation assay was performed as reported previously4 (link),31 . Briefly, 4 μg of biotinylated HIF2α-CODD peptide was immobilized on streptavidin-agarose beads. Following immobilization, the beads were washed 2× with EBC buffer (50 mM Tris–HCl, 120 mM NaCl, 0.5% (v/v) NP-40) and then 2× with 50 mM Tris–HCl pH 7.5. The immobilized peptides were then incubated with 7.5 μg HIS6-PHD2 (residues 181–426) in 500 μl of 50 mM Tris–HCl pH 7.5, 300 μM α-ketoglutarate, 2 mM ascorbic acid, 1 mM dithiothreitol, and 150 μM FeCl2 at room temperature for 1.5 h with gentle agitation. The beads were washed 5× with EBC buffer. Immobilized peptides were then incubated with HA-pVHL30, produced via in vitro transcription and translation in rabbit reticulocyte lysate (Promega), at 4 °C for 1.5 h in EBC buffer with 1× EDTA-free SigmaFast protease inhibitor (Sigma-Aldrich). The beads were again washed 5× with EBC buffer. Immobilized material was boiled in 1× SDS-PAGE sample buffer to elute protein and HA-pVHL30 protein amounts were examined via Western blot as a surrogate for hydroxylation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!